| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |